A structural explanation for these findings was provided from our previous cryo-EM structures of CT(Pro32) and rAmy(Tyr37)-bound AMYRs structures where the bulky phenolic side chain of Y37 rAmy forms perpendicular stacking interactions with W79 ECD 15 , and additional interactions with the respective RAMP protomer that are likely important for selectivity of rAmy for AMYRs over CTR
A fifth Aspect of the invention includes the first through the fourth Aspects of the invention, wherein the at least one builder is at least one compound selected from the group consisting of: tripolyphosphates, nitriloacetic acid salts, zeolites, calcite/carbonate, citrate or polymers, sodium, pyrophosphate, orthophosphate, sodium aluminosilicate, inorganic salts of alkaline agents, inorganic salts of alkali metals, sulphates, silicates, and metasilicates A sixth Aspect of the invention includes the first through the fifth Aspects of the invention further comprising: at least one bleach
No testing documentation: "Trust us, it's pure" isn't good enough
Chronic fatigue syndrome, itching and watery eyes, earache, nasal congestion, post nasal drip, sinus pressure/pain and throat clearing, shortness of breath, nausea, vomiting, diarrhea, abdominal pain, chronic pain, hives, itching, skin rash, headache, weakness, dizziness, allergic reactions to various food and drugs, nystagmus, tremors, recurrent arrhythmias, low blood pressure, syncope and near syncope, palpitations (postural orthostatic tachycardia syndrome) and anaphylactic shock are all possible symptoms
